METABOLISM \ BIOTRANSFORMATION: A. There are whole families of enzymes specialized for metabolism of compounds which would otherwise reach toxic levels in the body. 1. the Cytochrome P450 monooxygenase family: Major catalysts of drug biotransformation a. very ancient enzymes - 3.5 billion years! b. Heme-containing membrane proteins localized in smooth ER of numerous tissues c. Typically oxidize drugs and endogenous hormones through a wide variety of processes d. At least 12 families in humans; of these three families, CYP1, CYP2 and CYP3 do most drug biotransformation, CYP3 in particular 2. Hydrolytic Enzymes: a. Epoxide hydrolase is localized on ER close to cytochrome P450, further metabolizing reactive products of P450 b. Protease, peptidase enzymes in most tissues, transform polypeptide drugs 3. Conjugation reactions: Enzymes conjugate drugs with glucoronide (glucoronidation) to render them water-soluble, hence easily eliminated a. Less commonly, drugs are conjugated via sulfation or acetylation SEE TABLE FOR MORE DETAILS: B. THE LIVER: A primary site for metabolic conversion /detoxification of exogenous and endogenous compounds 1. Alcohol dehydrogenase - 15% in gut, rest in liver 2. P450 - concentrated in liver, gut 3. Common glucuronidation enzymes also concentrated in the liver C. Metabolism: 1. often more than one metabolic product 2. metabolites generally more ionized, hence more easily eliminated in urine 3. SOME metabolites more active/toxic than parent compound D. Factors affecting drug biotransformation: 1. Enzyme INDUCTION: a. Exposure to P450 substrates (drugs) can increase P450 enzymes many-fold i. Same true for glucuronidation b. Common mechanism of drug TOLERANCE and CROSS-TOLERANCE 2. Enzyme INHIBITION: a. Can cause desirable or TOXIC increases in drug levels b. Often caused by metabolic drug interactions between two compounds with affinity for the same P450 c. Some compounds bind tightly to the heme complex in P450 - Cimetidine, Ketoconazole d. Some compounds are "suicide inactivators" of P450s, destroying the heme complex - Secobarbital, synthetic steroids 3. Individual differences and Genetic Polymorphisms a. There are LARGE individual differences in drug biotransformation b. These are often due to genetic differences in metabolic enzymes/pathways i. Extensive (rapid) metabolizers ii. Poor (slow) metabolizers iii. Which is worse depends upon whether the drug or the metabolite is toxic! 4. Disease - especially liver disease, can impair drug metabolism 5. Age - principally P450 activity decreases with age